According to CareDx's latest financial reports and stock price the company's current Operating Margin is -24.00%. At the end of 2021 the company had an Operating Margin of -10.83%.
Year | Operating Margin | Change |
---|---|---|
2021 | -10.83% | 5.35% |
2020 | -10.28% | -45.47% |
2019 | -18.85% | -70.07% |
2018 | -62.97% | -46.87% |
2017 | -118.51% | 16.42% |
2016 | -101.80% | 109.02% |
2015 | -48.70% | 1749.63% |
2014 | -2.63% | -83.57% |
2013 | -16.03% | -35.2% |
2012 | -24.74% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
T2 Biosystems
TTOO | -252.10% | 950.42% | ๐บ๐ธ USA |
Agios Pharmaceuticals
AGIO | -1,990.40% | 8,193.33% | ๐บ๐ธ USA |
Invitae
NVTA | -610.33% | 2,443.04% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.